Psoriasis of Scalp Clinical Trial
Official title:
Long-term Treatment of Scalp Psoriasis With Calcipotriol Plus Betamethasone Dipropionate Gel
The purpose of the trial is to study the safety and efficacy of long term use of once daily
applications, as needed, of calcipotriol plus betamethasone dipropionate gel, as compared to
calcipotriol alone in the same gel.
The primary response criteria will be the incidence of adverse drug reactions of any type,
and the incidence of adverse events of concern associated with long-term corticosteroid use
on the scalp.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00243464 -
Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis
|
Phase 3 | |
| Recruiting |
NCT05144165 -
Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
|
||
| Completed |
NCT05105139 -
Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp
|
||
| Completed |
NCT00216827 -
Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis
|
Phase 3 | |
| Recruiting |
NCT04099979 -
A Pilot Study to Explore the Role of Gut Flora in Psoriasis
|
||
| Not yet recruiting |
NCT03553433 -
Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis
|
Phase 4 | |
| Recruiting |
NCT05938361 -
Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis
|
||
| Recruiting |
NCT05858632 -
Immune Spatial Features of Guselkumab Cutaneous Response
|
Phase 4 | |
| Completed |
NCT00216840 -
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis
|
Phase 3 |